NCT04915144 2023-02-21177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETsBritish Columbia Cancer AgencyPhase 2 Withdrawn
NCT02108782 2017-07-19Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsAcademic and Community Cancer Research UnitedPhase 2 Withdrawn